Related references
Note: Only part of the references are listed.British Society for Rheumatology guideline on prescribing drugs in pregnancy and breastfeeding: immunomodulatory anti-rheumatic drugs and corticosteroids
Mark D. Russell et al.
RHEUMATOLOGY (2023)
Obinutuzumab in connective tissue diseases after former rituximab-non-response: a case series
Peter Kvacskay et al.
ANNALS OF THE RHEUMATIC DISEASES (2022)
Disparity in peripheral and renal B-cell depletion with rituximab in systemic lupus erythematosus: an opportunity for obinutuzumab?
Venkat R. Reddy et al.
RHEUMATOLOGY (2022)
Eculizumab use in catastrophic antiphospholipid syndrome (CAPS): Descriptive analysis from the CAPS Registry
Brenda Lopez-Benjume et al.
AUTOIMMUNITY REVIEWS (2022)
Refractory antiphospholipid antibody syndrome-induced thrombocytopaenia successfully treated with belimumab
Riku Yoshizuka et al.
LUPUS (2022)
Treatment advances in antiphospholipid syndrome: 2022 update
Zeynep Belce Erton et al.
CURRENT OPINION IN PHARMACOLOGY (2022)
Simultaneous crosslinking of CD20 and CD38 receptors by drug-free macromolecular therapeutics enhances B cell apoptosis in vitro and in vivo
M. Tommy Gambles et al.
JOURNAL OF CONTROLLED RELEASE (2022)
Low dose versus standard dose rituximab for the treatment of antiphospholipid syndrome: A pilot study from a tertiary medical center
Yuzhou Gan et al.
FRONTIERS IN IMMUNOLOGY (2022)
Bruton tyrosine kinase inhibitors in B-cell lymphoma: beyond the antitumour effect
Haoran Wang et al.
EXPERIMENTAL HEMATOLOGY & ONCOLOGY (2022)
A Case of Probable Catastrophic Antiphospholipid Syndrome Treated With Rituximab and Without Anticoagulation
Lawrence Wayne Liu et al.
JCR-JOURNAL OF CLINICAL RHEUMATOLOGY (2021)
Antiphospholipid syndrome: Complement activation, complement gene mutations, and therapeutic implications
Shruti Chaturvedi et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2021)
Monitoring of anticoagulation in thrombotic antiphospholipid syndrome
Hannah Cohen et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2021)
Successful outcome with eculizumab treatment in a patient with antiphospholipid syndrome presenting with an unusual thrombotic storm
Jones T. Nauseef et al.
JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2021)
Pediatric Catastrophic Antiphospholipid Syndrome Successfully Treated with Eculizumab
Ignacio Oulego-Erroz et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2021)
The growing role of precision medicine for the treatment of autoimmune diseases; results of a systematic review of literature and Experts' Consensus
Roberto Giacomelli et al.
AUTOIMMUNITY REVIEWS (2021)
B cells in primary antiphospholipid syndrome: Review and remaining challenges
Yannick Dieudonne et al.
AUTOIMMUNITY REVIEWS (2021)
A Case Report of COVID-Associated Catastrophic Antiphospholipid Syndrome Successfully Treated with Eculizumab
Anusha Chidharla et al.
JOURNAL OF BLOOD MEDICINE (2021)
Case Report: Resetting the Humoral Immune Response by Targeting Plasma Cells With Daratumumab in Anti-Phospholipid Syndrome
Daniel E. Pleguezuelo et al.
FRONTIERS IN IMMUNOLOGY (2021)
Expert Perspective: Management of Microvascular and Catastrophic Antiphospholipid Syndrome
Doruk Erkan
ARTHRITIS & RHEUMATOLOGY (2021)
Successful Treatment of Catastrophic Antiphospholipid Syndrome Using Rituximab: Case Report and Review of the Literature
Cristina Stanescu et al.
MEDICINA-LITHUANIA (2021)
Effect of belimumab treatment on antiphospholipid antibody levels: post-hoc analysis based on two randomised placebo-controlled trials in systemic lupus erythematosus
Katerina Chatzidionysiou et al.
ANNALS OF THE RHEUMATIC DISEASES (2020)
Induction of tissue factor expression by anti-β2-glycoprotein I is mediated by tumor necrosis factor α
Anne Hollerbach et al.
JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2020)
Complement activity and complement regulatory gene mutations are associated with thrombosis in APS and CAPS
Shruti Chaturvedi et al.
BLOOD (2020)
Thrombotic microangiopathy in the course of catastrophic antiphospholipid syndrome successfully treated with eculizumab: case report and systematic review of the literature
Marta Skoczynska et al.
LUPUS (2020)
Treatment of antiphospholipid syndrome
Massimo Radin et al.
CLINICAL IMMUNOLOGY (2020)
16th International Congress on Antiphospholipid Antibodies Task Force Report on Antiphospholipid Syndrome Treatment Trends
Hannah Cohen et al.
LUPUS (2020)
Targeting CD38 with Daratumumab in Refractory Systemic Lupus Erythematosus
Lennard Ostendorf et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
A case of successful pregnancy following multidrug treatment including rituximab and intravenous immunoglobulin for primary antiphospholipid antibody syndrome refractory to conventional treatment
Mayu Nagata et al.
MODERN RHEUMATOLOGY CASE REPORTS (2020)
Digital ischaemia secondary to adalimumab-induced antiphospholipid syndrome
Shashank Cheemalavagu et al.
BMJ CASE REPORTS (2020)
Treatment of antiphospholipid syndrome beyond anticoagulation
Chrisanna Dobrowolski et al.
CLINICAL IMMUNOLOGY (2019)
Long-term effect of B-cells depletion alone as rescue therapy for severe thrombocytopenia in primary antiphospholipid syndrome
Savino Sciascia et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2019)
Circulating plasmablasts contribute to antiphospholipid antibody production, associated with type I interferon upregulation
Ryo Hisada et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2019)
Treatment of refractory poor aPL-related obstetric outcomes with TNF-alpha blockers: Maternal-fetal outcomes in a series of 18 cases
Jaume Alijotas-Reig et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2019)
The Extended Use of Eculizumab in Pregnancy and Complement Activation-Associated Diseases Affecting Maternal, Fetal and Neonatal Kidneys-The Future Is Now?
Vedran Stefanovic
JOURNAL OF CLINICAL MEDICINE (2019)
Eculizumab in refractory catastrophic antiphospholipid syndrome: a case report and systematic review of the literature
Maria Giulia Tinti et al.
CLINICAL AND EXPERIMENTAL MEDICINE (2019)
Antiphospholipid syndrome: a clinical review
Veronica Mezhov et al.
MEDICAL JOURNAL OF AUSTRALIA (2019)
Managing antiphospholipid syndrome in pregnancy
Karen Schreiber et al.
THROMBOSIS RESEARCH (2019)
Management of antiphospholipid syndrome
Imad Uthman et al.
ANNALS OF THE RHEUMATIC DISEASES (2019)
Secondary thrombotic microangiopathy in systemic lupus erythematosus and antiphospholipid syndrome, the role of complement and use of eculizumab: Case series and review of literature
Nina Kello et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2019)
Anticardiolipin and anti-beta 2 glycoprotein-I antibodies disappearance in patients with systemic lupus erythematosus and antiphospholipid syndrome while on belimumab
Savino Sciascia et al.
ANNALS OF THE RHEUMATIC DISEASES (2018)
Peripheral B-Cell Subset Distribution in Primary Antiphospholipid Syndrome
Lorena Alvarez-Rodriguez et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
The diagnosis and clinical management of the catastrophic antiphospholipid syndrome: A comprehensive review
Ricard Cervera et al.
JOURNAL OF AUTOIMMUNITY (2018)
McMaster RARE-Bestpractices clinical practice guideline on diagnosis and management of the catastrophic antiphospholipid syndrome
K. Legault et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2018)
Microthrombotic renal involvement in an SLE patient with concomitant catastrophic antiphospholipid syndrome: the beneficial effect of rituximab treatment
A. Dioszegi et al.
LUPUS (2018)
Role of Bruton's tyrosine kinase in B cells and malignancies
Simar Pal Singh et al.
MOLECULAR CANCER (2018)
Diagnosis and Management of the Antiphospholipid Syndrome
David Garcia et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
The effect of triple therapy on the mortality of catastrophic anti-phospholipid syndrome patients
Ignasi Rodriguez-Pinto et al.
RHEUMATOLOGY (2018)
Eculizumab for catastrophic antiphospholipid syndrome-a case report and literature review
Mathilde Guillot et al.
RHEUMATOLOGY (2018)
The complex treatment including rituximab in the Management of Catastrophic Antiphospholid Syndrome with renal involvement
Aleksandra Rymarz et al.
BMC NEPHROLOGY (2018)
Antiphospholipid syndrome
Karen Schreiber et al.
NATURE REVIEWS DISEASE PRIMERS (2018)
Eculizumab in a pregnant patient with laboratory onset of catastrophic antiphospholipid syndrome A case report
Patrizia Rovere-Querini et al.
MEDICINE (2018)
beta 2-Glycoprotein I-Reactive T Cells in Autoimmune Disease
Joyce Rauch et al.
FRONTIERS IN IMMUNOLOGY (2018)
Integrative analysis reveals CD38 as a therapeutic target for plasma cell-rich pre-disease and established rheumatoid arthritis and systemic lupus erythematosus
Suzanne Cole et al.
ARTHRITIS RESEARCH & THERAPY (2018)
Immunomodulation in the Treatment of Refractory Catastrophic Antiphospholipid Syndrome
Karthik Nath et al.
CASE REPORTS IN HEMATOLOGY (2018)
Increased B-cell activating factor (BAFF)/B-lymphocyte stimulator (BLyS) in primary antiphospholipid syndrome is associated with higher adjusted global antiphospholipid syndrome scores
Lucas L. van den Hoogen et al.
RMD OPEN (2018)
CD38 antibodies in multiple myeloma: back to the future
Niels W. C. J. van de Donk et al.
BLOOD (2018)
Severe antiphospholipid antibody syndrome - response to plasmapheresis and rituximab
Paraskevi Gkogkolou et al.
JOURNAL OF DERMATOLOGICAL TREATMENT (2017)
Antiphospholipid antibody-induced cellular responses depend on epitope specificity : implications for treatment of antiphospholipid syndrome
N. Mueller-Calleja et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2017)
Detrimental roles of TNF-alpha in the antiphospholipid syndrome and de novo synthesis of antiphospholipid antibodies induced by biopharmaceuticals against TNF-alpha
Mirjana Becarevic
JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2017)
Effect on mother and child of eculizumab given before caesarean section in a patient with severe antiphospholipid syndrome A case report
Alice Gustavsen et al.
MEDICINE (2017)
The complement system as a potential therapeutic target in rheumatic disease
Leendert A. Trouw et al.
NATURE REVIEWS RHEUMATOLOGY (2017)
Obinutuzumab induces superior B-cell cytotoxicity to rituximab in rheumatoid arthritis and systemic lupus erythematosus patient samples
Venkat Reddy et al.
RHEUMATOLOGY (2017)
Monocentric experience of the rituximab therapy in systemic lupus erythematosus-associated antiphospholipid syndrome with warfarin therapy failure
Chrong-Reen Wang et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2017)
Complement inhibition with eculizumab for thrombotic microangiopathy rescues a living-donor kidney transplant in a patient with antiphospholipid antibody syndrome
Praveen Ramakrishnan Geethakumari et al.
TRANSFUSION AND APHERESIS SCIENCE (2017)
In Vivo Role of Neutrophil Extracellular Traps in Antiphospholipid Antibody-Mediated Venous Thrombosis
He Meng et al.
ARTHRITIS & RHEUMATOLOGY (2017)
Continous Rituximab treatment for recurrent diffuse alveolar hemorrhage in a patient with systemic lupus erythematosus and antiphosholipid syndrome
Signe Aakjaer et al.
RESPIRATORY MEDICINE CASE REPORTS (2017)
Use of eculizumab in a systemic lupus erythemathosus patient presenting thrombotic microangiopathy and heterozygous deletion in CFHR1-CFHR3. A case report and systematic review
Maria Izabel de Holanda et al.
CLINICAL RHEUMATOLOGY (2017)
Diagnosis and management of the antiphospholipid syndrome
Shruti Chaturvedi et al.
BLOOD REVIEWS (2017)
European evidence-based recommendations for diagnosis and treatment of paediatric antiphospholipid syndrome: the SHARE initiative
Noortje Groot et al.
ANNALS OF THE RHEUMATIC DISEASES (2017)
Achieving a satisfactory clinical and biochemical response in antiphospholipid syndrome and severe thrombocytopenia with rituximab: two case reports
Donia Gamoudi et al.
CLINICAL CASE REPORTS (2017)
Catastrophic antiphospholipid syndrome treated with rituximab: A case report
Atalay Dogru et al.
EUROPEAN JOURNAL OF RHEUMATOLOGY (2017)
A case of relapsing and refractory catastrophic anti-phospholipid syndrome successfully managed with eculizumab, a complement 5 inhibitor
Surabhi Wig et al.
RHEUMATOLOGY (2016)
Pregnancy outcomes of patients with paroxysmal nocturnal hemoglobinuria treated with eculizumab: a Japanese experience and updated review
Naoyuki Miyasaka et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2016)
The Therapeutic CD38 Monoclonal Antibody Daratumumab Induces Programmed Cell Death via Fcγ Receptor-Mediated Cross-Linking
Marije B. Overdijk et al.
JOURNAL OF IMMUNOLOGY (2016)
Rituximab usage in systemic lupus erythematosus-associated antiphospholipid syndrome: A single-center experience
Chrong-Reen Wang et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2016)
The Role of Complement Inhibition in Thrombotic Angiopathies and Antiphospholipid Syndrome
Doruk Erkan et al.
TURKISH JOURNAL OF HEMATOLOGY (2016)
Repeated low-dose courses of rituximab in SLE-associated antiphospholipid syndrome: Data from a tertiary dedicated centre
Giacomo Emmi et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2016)
Meningococcal Vaccinations
Nancy Crum-Cianflone et al.
INFECTIOUS DISEASES AND THERAPY (2016)
The clinical significance of antiphospholipid antibodies in systemic lupus erythematosus
Ozan Unlu et al.
EUROPEAN JOURNAL OF RHEUMATOLOGY (2016)
Antiphospholipid syndrome and the heart: A case series and literature review
Gentian Denas et al.
AUTOIMMUNITY REVIEWS (2015)
Update on the pathogenesis and treatment of the antiphospholipid syndrome
Cecilia Beatrice Chighizola et al.
CURRENT OPINION IN RHEUMATOLOGY (2015)
Eculizumab Induces Sustained Remission in a Patient With Refractory Primary Catastrophic Antiphospholipid Syndrome
Thomas A. Zikos et al.
JCR-JOURNAL OF CLINICAL RHEUMATOLOGY (2015)
Prevention of Defective Placentation and Pregnancy Loss by Blocking Innate Immune Pathways in a Syngeneic Model of Placental Insufficiency
Shari E. Gelber et al.
JOURNAL OF IMMUNOLOGY (2015)
Efficacy and safety of rituximab in the treatment of primary antiphospholipid syndrome: Analysis of 24 cases from the bibliography review
Isaac Pons et al.
MEDICINA CLINICA (2015)
Eculizumab in Pregnant Patients with Paroxysmal Nocturnal Hemoglobinuria
Richard J. Kelly et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Infliximab improves endothelial dysfunction in a mouse model of antiphospholipid syndrome: Role of reduced oxidative stress
Ygal Benhamou et al.
VASCULAR PHARMACOLOGY (2015)
Release of Neutrophil Extracellular Traps by Neutrophils Stimulated With Antiphospholipid Antibodies: A Newly Identified Mechanism of Thrombosis in the Antiphospholipid Syndrome
Srilakshmi Yalavarthi et al.
ARTHRITIS & RHEUMATOLOGY (2015)
Morbidity and mortality in the antiphospholipid syndrome during a 10-year period: a multicentre prospective study of 1000 patients
R. Cervera et al.
ANNALS OF THE RHEUMATIC DISEASES (2015)
Eculizumab Prevents Recurrent Antiphospholipid Antibody Syndrome and Enables Successful Renal Transplantation
B. E. Lonze et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2014)
PREGNANCY OUTCOMES FOR SYSTEMIC LUPUS ERYTHEMATOSUS (SLE) SUBJECTS WITH CONCEPTION DURING BELIMUMAB INTRAVENOUS (IV) AND SUBCUTANEOUS (SC) PLACEBO-CONTROLLED CLINICAL TRIALS AND LONG TERM EXTENSION TRIALS
M. Powell et al.
ANNALS OF THE RHEUMATIC DISEASES (2014)
Platelets are required for enhanced activation of the endothelium and fibrinogen in a mouse thrombosis model of APS
Valerie Proulle et al.
BLOOD (2014)
Renal involvement in antiphospholipid syndrome
Savino Sciascia et al.
NATURE REVIEWS NEPHROLOGY (2014)
Opportunity Cost of Funding Drugs for Rare Diseases: The Cost-Effectiveness of Eculizumab in Paroxysmal Nocturnal Hemoglobinuria
Doug Coyle et al.
MEDICAL DECISION MAKING (2014)
Efficacy of Eculizumab in a Patient With Immunoadsorption-Dependent Catastrophic Antiphospholipid Syndrome: A Case Report
Andreas Kronbichler et al.
MEDICINE (2014)
A Case of Thrombotic Microangiopathy Associated With Antiphospholipid Antibody Syndrome Successfully Treated With Eculizumab
Omid Bakhtar et al.
TRANSPLANTATION (2014)
36-Year-Old Female with Catastrophic Antiphospholipid Syndrome Treated with Eculizumab: A Case Report and Review of Literature
Marianna Strakhan et al.
CASE REPORTS IN HEMATOLOGY (2014)
Eculizumab Improves Posttransplant Thrombotic Microangiopathy Due to Antiphospholipid Syndrome Recurrence but Fails to Prevent Chronic Vascular Changes
G. Canaud et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2013)
A Pilot Open-Label Phase II Trial of Rituximab for Non-Criteria Manifestations of Antiphospholipid Syndrome
Doruk Erkan et al.
ARTHRITIS AND RHEUMATISM (2013)
Rituximab use in the catastrophic antiphospholipid syndrome: Descriptive analysis of the CAPS registry patients receiving rituximab
Horacio Berman et al.
AUTOIMMUNITY REVIEWS (2013)
Successful plasma exchange combined with rituximab therapy in aggressive APS-related cutaneous necrosis
Rubens Costa et al.
CLINICAL RHEUMATOLOGY (2013)
Adalimumab-associated antiphospholipid syndrome: a case report and review of the literature
Iman Hemmati et al.
CLINICAL RHEUMATOLOGY (2013)
Anti-β2GPI/β2GPI induced TF and TNF-α expression in monocytes involving both TLR4/MyD88 and TLR4/TRIF signaling pathways
Hongxiang Xie et al.
MOLECULAR IMMUNOLOGY (2013)
Annexin A5 anticoagulant activity in children with systemic lupus erythematosus and the association with antibodies to domain I of β2-glycoprotein I
D. M. Wahezi et al.
LUPUS (2013)
Epitope interactions of monoclonal antibodies targeting CD20 and their relationship to functional properties
Christian Klein et al.
MABS (2013)
Receptors involved in cell activation by antiphospholipid antibodies
Karim J. Brandt et al.
THROMBOSIS RESEARCH (2013)
Brief Report: Induction of sustained remission in recurrent catastrophic antiphospholipid syndrome via inhibition of terminal complement with eculizumab
Iuliana Shapira et al.
ARTHRITIS AND RHEUMATISM (2012)
B-cell directed therapies in antiphospholipid antibody syndrome - New directions based on murine and human data
Saakshi Khattri et al.
AUTOIMMUNITY REVIEWS (2012)
Rituximab induces resolution of recurrent diffuse alveolar hemorrhage in a patient with primary antiphospholipid antibody syndrome
A. Scheiman Elazary et al.
LUPUS (2012)
Activation of MAPKs in the anti-β2GPI/β2GPI-induced tissue factor expression through TLR4/IRAKs pathway in THP-1 cells
Hong Zhou et al.
THROMBOSIS RESEARCH (2012)
Management of refractory anti-phospholipid syndrome
Tina Scoble et al.
AUTOIMMUNITY REVIEWS (2011)
Daratumumab, a Novel Therapeutic Human CD38 Monoclonal Antibody, Induces Killing of Multiple Myeloma and Other Hematological Tumors
Michel de Weers et al.
JOURNAL OF IMMUNOLOGY (2011)
Phenotypic Changes of Lymphocytes in Patients with Systemic Lupus Erythematosus Who Are in Longterm Remission After B Cell Depletion Therapy with Rituximab
Shigeru Iwata et al.
JOURNAL OF RHEUMATOLOGY (2011)
Treatment-induced downregulation of antiphospholipid antibodies: effect of rituximab alone on clinical and laboratory features of antiphospholipid syndrome
S. Sciascia et al.
LUPUS (2011)
Hydroxychloroquine protects the annexin A5 anticoagulant shield from disruption by antiphospholipid antibodies: evidence for a novel effect for an old antimalarial drug
Jacob H. Rand et al.
BLOOD (2010)
Longterm Safety of Patients Receiving Rituximab in Rheumatoid Arthritis Clinical Trials
Ronald F. van Vollenhoven et al.
JOURNAL OF RHEUMATOLOGY (2010)
Eculizumab and Renal Transplantation in a Patient with CAPS.
Bonnie E. Lonze et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Severe acute thrombotic exacerbation in two cases with anti-phospholipid syndrome after retreatment with rituximab in phase I/II clinical trial for refractory systemic lupus erythematosus
K. Suzuki et al.
RHEUMATOLOGY (2009)
Successful treatment of catastrophic antiphospholipid antibody syndrome (CAPS) associated with splenic marginal-zone lymphoma with low-molecular weight heparin, rituximab and bendamustine
Hendrik Manner et al.
AMERICAN JOURNAL OF THE MEDICAL SCIENCES (2008)
Prevention of murine antiphospholipid syndrome by BAFF blockade
Philip Kahn et al.
ARTHRITIS AND RHEUMATISM (2008)
Autoimmune diseases induced by TNF-targeted therapies
Manuel Ramos-Casals et al.
BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY (2008)
Successful treatment of life-threatening Evans syndrome due to antiphospholipid antibody syndrome by rituximab-based regimen: a case with long-term follow-up
A. Ruckert et al.
LUPUS (2008)
FDA Report: Eculizumab (Soliris (R)) for the Treatment of Patients with Paroxysmal Nocturnal Hemoglobinuria
Andrew Dmytrijuk et al.
ONCOLOGIST (2008)
Evolution and function of the ADP ribosyl cyclase/CD38 gene family in physiology and pathology
Fabio Malavasi et al.
PHYSIOLOGICAL REVIEWS (2008)
Anti-β2-Glycoprotein I antibodies induce monocyte release of tumor necrosis factor α and tissue factor by signal transduction pathways involving lipid rafts
Maurizio Sorice et al.
ARTHRITIS AND RHEUMATISM (2007)
Decreased anticoagulant response to tissue factor pathway inhibitor type 1 in plasmas from patients with lupus anticoagulants
Sigurd Liestol et al.
BRITISH JOURNAL OF HAEMATOLOGY (2007)
A human monoclonal antiprothrombin antibody is thrombogenic in vivo and upregulates expression of tissue factor and E-selectin on endothelial cells
Mariano Vega-Ostertag et al.
BRITISH JOURNAL OF HAEMATOLOGY (2006)
Anti-β2-glycoprotein I antibodies in complex with β2-glycoprotein I can activate platelets in a dysregulated manner via glycoprotein Ib-IX-V
Tong Shi et al.
ARTHRITIS AND RHEUMATISM (2006)
International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)
S Miyakis et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2006)
Thrombus formation induced by antibodies to β2-glycoprotein I is complement dependent and requires a priming factor
F Fischetti et al.
BLOOD (2005)
Requirement of activation of complement C3 and C5 for antiphospholipid antibody-mediated thrombophilia
SS Pierangeli et al.
ARTHRITIS AND RHEUMATISM (2005)
Annexin A2 mediates endothelial cell activation by antiphospholipid/anti-β2 glycoprotein I antibodies
JW Zhang et al.
BLOOD (2005)
TNF-alpha is a critical effector and a target for therapy in antiphospholipid antibody-induced pregnancy loss
J Berman et al.
JOURNAL OF IMMUNOLOGY (2005)
Heparin prevents antiphospholipid antibody-induced fetal loss by inhibiting complement activation
G Girardi et al.
NATURE MEDICINE (2004)
Share Paper
